ALGS vs CB
Aligos Therapeutics Inc (ALGS) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
ALGS currently screens at market cap $44.1M. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the ALGS and CB stock pages for the full models.
Not investment advice.